Diagnosing COVID-19: the disease and tools for detection B Udugama, P Kadhiresan, HN Kozlowski, A Malekjahani, M Osborne, ... ACS nano 14 (4), 3822-3835, 2020 | 1894 | 2020 |
Acute myocardial infarction after laboratory-confirmed influenza infection JC Kwong, KL Schwartz, MA Campitelli, H Chung, NS Crowcroft, ... New England Journal of Medicine 378 (4), 345-353, 2018 | 1264 | 2018 |
Low 2012–13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses DM Skowronski, NZ Janjua, G De Serres, S Sabaiduc, A Eshaghi, ... PloS one 9 (3), e92153, 2014 | 485 | 2014 |
Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario S Nasreen, H Chung, S He, KA Brown, JB Gubbay, SA Buchan, DB Fell, ... Nature microbiology 7 (3), 379-385, 2022 | 426 | 2022 |
Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication AR Eshaghi, VR Duvvuri, R Lai, JT Nadarajah, A Li, SN Patel, DE Low, ... PloS one 7 (3), e32807, 2012 | 371 | 2012 |
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study H Chung, S He, S Nasreen, ME Sundaram, SA Buchan, SE Wilson, ... bmj 374, 2021 | 334 | 2021 |
Estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes SA Buchan, H Chung, KA Brown, PC Austin, DB Fell, JB Gubbay, ... JAMA network open 5 (9), e2232760-e2232760, 2022 | 316 | 2022 |
Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide S Isabel, L Graña-Miraglia, JM Gutierrez, C Bundalovic-Torma, HE Groves, ... Scientific reports 10 (1), 14031, 2020 | 228 | 2020 |
A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014–2015 season DM Skowronski, C Chambers, S Sabaiduc, G De Serres, AL Winter, ... Clinical Infectious Diseases 63 (1), 21-32, 2016 | 218 | 2016 |
The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study HE Groves, PP Piché-Renaud, A Peci, DS Farrar, S Buckrell, C Bancej, ... The Lancet Regional Health–Americas 1, 2021 | 195 | 2021 |
Diagnosis and management of first case of COVID-19 in Canada: lessons applied from SARS-CoV-1 X Marchand-Senécal, R Kozak, S Mubareka, N Salt, JB Gubbay, ... Clinical Infectious Diseases 71 (16), 2207-2210, 2020 | 162 | 2020 |
Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A (H3N2) epidemics in Canada, 2010–2011 to 2014–2015 DM Skowronski, C Chambers, G De Serres, S Sabaiduc, AL Winter, ... The Journal of infectious diseases 215 (7), 1059-1099, 2017 | 161 | 2017 |
Genetic diversity and evolutionary insights of respiratory syncytial virus A ON1 genotype: global and local transmission dynamics VR Duvvuri, A Granados, P Rosenfeld, J Bahl, A Eshaghi, JB Gubbay Scientific reports 5 (1), 14268, 2015 | 137 | 2015 |
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009 DM Skowronski, NZ Janjua, G De Serres, TS Hottes, JA Dickinson, ... Bmj 342, 2011 | 133 | 2011 |
Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories JJ LeBlanc, JB Gubbay, Y Li, R Needle, SR Arneson, D Marcino, ... Journal of Clinical Virology 128, 104433, 2020 | 131 | 2020 |
Pandemic H1N1 influenza infection and vaccination in humans induces cross-protective antibodies that target the hemagglutinin stem CA Thomson, Y Wang, LM Jackson, M Olson, W Wang, A Liavonchanka, ... Frontiers in immunology 3, 87, 2012 | 131 | 2012 |
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010–2011 season DM Skowronski, NZ Janjua, G De Serres, AL Winter, JA Dickinson, ... Clinical infectious diseases 55 (3), 332-342, 2012 | 127 | 2012 |
Influenza A/subtype and B/lineage effectiveness estimates for the 2011–2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine DM Skowronski, NZ Janjua, S Sabaiduc, G De Serres, AL Winter, ... The Journal of infectious diseases 210 (1), 126-137, 2014 | 126 | 2014 |
Older age and a reduced likelihood of 2009 H1N1 virus infection DN Fisman, R Savage, J Gubbay, C Achonu, H Akwar, DJ Farrell, ... New England Journal of Medicine 361 (20), 2000-2001, 2009 | 125 | 2009 |
Interim estimates of 2014/15 vaccine effectiveness against influenza A (H3N2) from Canada’s Sentinel Physician Surveillance Network, January 2015 DM Skowronski, C Chambers, S Sabaiduc, G De Serres, JA Dickinson, ... Eurosurveillance 20 (4), 21022, 2015 | 124 | 2015 |